Home » Analysis » What does SECT 505(b)(2) mean in Analysis?

SECT 505(b)(2) in Analysis Meaning

The SECT 505(b)(2) meaning in Analysis terms is "New Drug Application". There are 1 related meanings of the SECT 505(b)(2) Analysis abbreviation.

SECT 505(b)(2) on Analysis Full Forms

  1. New Drug Application A document whereby a pharmaceutical manufacturer or its agent requests permission from the United States Food and Drug Administration (FDA) for a license to market a drug for one or more specified indications; besides a chemical and pharmacologic description of the drug, the application must show the results of clinical trials conducted with respect to the indication for which a license is requested.

Frequently Asked Questions (FAQ)

  1. What does SECT 505(b)(2) stand for Analysis?

    SECT 505(b)(2) stands for New Drug Application in Analysis terms.

  2. What is the shortened form of New Drug Application in Analysis?

    The short form of "New Drug Application" is SECT 505(b)(2) for Analysis.

Citation

SECT 505(b)(2) in Analysis. Acronym24.com. (2020, May 24). Retrieved January 3, 2025 from https://acronym24.com/sect-505-b-2-meaning-in-analysis/

Last updated